WhichSpecialistIndependent specialist research · not medical advice
Sample report — fictional patient. The specialists, programs and links are real and were checked on the date shown; the patient is invented to show what you receive.
← Back to WhichSpecialist
Your Specialist Report — Primary Sclerosing Cholangitis (PSC) with Ulcerative Colitis
Prepared for: D.K. (sample patient, man, age 57) · Location: Columbus, Ohio · Insurance: employer PPO · Report date: November 2, 2026
Bottom line
• First choice for PSC depth: Dr. John Eaton, Mayo Clinic, Rochester, Minnesota. His page lists PSC trials and PSC biomarkers as interests, and his 2025–2026 papers cover finding bile duct cancer early in PSC and colon pre-cancer in PSC with inflammatory bowel disease. It is the farthest option (a flight, or about 11 hours by car).
• Closest PSC-named specialist: Dr. Craig Lammert, IU Health, Indianapolis (about 2 h 45 min by car). His page names PSC and says he is accepting new patients. IU is the closest site we found recruiting today for a large PSC drug trial (elafibranor); the only other Midwest site recruiting for it is the University of Iowa.
• Bile duct cancer focus: Dr. Nataliya Razumilava, Michigan Medicine, Ann Arbor (about 3 hours). Her page names cholangiocarcinoma (bile duct cancer) and bile duct disorders, though not PSC by name.
• In Columbus: Ohio State's liver team has a nurse practitioner whose page names PSC, and a liver transplant center. A sensible plan for many families: an expert center sets the plan; Columbus does the routine scans, labs and colonoscopies.
• What we could not settle from public pages: wait times, new-patient status for Mayo and Michigan, and video visits from Ohio. Those are the three questions for your first call (Section 3).
1. What this condition is
D.K.'s GI doctor has told him he has primary sclerosing cholangitis (PSC) and has asked the family to find a PSC specialist. PSC is a long-term liver disease. The bile ducts, the small tubes that carry bile out of the liver, become inflamed and scarred, and over time they narrow. Most people with PSC also have inflammatory bowel disease, most often ulcerative colitis. A teaching page from the American Association for the Study of Liver Diseases (AASLD, the U.S. liver doctors' society) says that people with PSC "are up to 400 times more likely" to develop cholangiocarcinoma (bile duct cancer) and also face a higher risk of gallbladder and colon cancer (AASLD page, February 27, 2024). That is why PSC care is mostly about watching closely over years: regular MRI scans of the bile ducts, regular colonoscopies, blood tests, and planning early for a liver transplant if the liver starts to fail. The same page says there is "currently no disease-modifying therapy for PSC". Care is usually led by a hepatologist (liver specialist) and shared with the GI doctor who treats the colitis. Your doctors will decide what applies to you; this report helps you prepare for those conversations.
What usually happens next. The first visit with a PSC specialist is usually a review of what has already been done: the MRI of the bile ducts (called MRCP), liver blood tests, any colonoscopy reports. Then the specialist sets a long-term plan. The AASLD page lists the checks that such a plan usually covers:
- bile duct cancer screening "annually, typically with an MRI/MRCP +/- serum CA 19-9" (a blood test);
- for people with PSC and colitis, colonoscopy "every 1-2 years with dysplasia surveillance" (looking for early pre-cancer changes);
- an ultrasound every 6 months if gallbladder polyps are present;
- liver cancer screening every 6 months only if cirrhosis (heavy scarring) is present.
The same page is honest that it is "unclear if current recommendations are adequate" to reduce deaths from bile duct cancer, and that a large Swedish study of yearly scans found no clear survival benefit. Section 7 turns this into questions.
2. Specialists to consider
How we chose. We started from the public provider list of PSC Partners Seeking a Cure (the main U.S. PSC patient nonprofit), dated April 2026, plus each hospital's own pages and the U.S. trial registry. We read the April 2026 list on November 2, 2026; it names dozens of clinicians at each large center (Mayo Clinic, Cleveland Clinic, Michigan Medicine, IU Health, Ohio State). PSC Partners says on its provider map page that it "does not endorse or recommend specific physicians or medical centers." Being on that list does not show PSC focus, and some entries are out of date (see "Leads we checked"). We ranked doctors first by how directly their own hospital page ties them to PSC or to PSC-related bile duct cancer, then by distance from Columbus. Drive times are rough estimates, not measured.
What PSC Partners already gives you, and what this report adds. We saw no fee to use the PSC Partners map. This report adds: each named doctor's current hospital page checked on November 2, 2026; stale list entries caught; open PSC trials in the Midwest checked against the U.S. registry today; and the calls, questions and insurance steps for a family in Columbus.
1. John E. Eaton, MD — Gastroenterologist and Transplant Hepatologist, Mayo Clinic
- Where they practice now: Mayo Clinic, Rochester, Minnesota (Gastroenterology and Hepatology; Liver Transplant Program). Checked on Mayo's own page on November 2, 2026: John E. Eaton, M.D. - Doctors and Medical Staff - Mayo Clinic
- Why selected:
- His Mayo page lists his interests as "Cholestatic liver disease", "Clinical trials PSC/PBC" and "Biomarkers PSC", and a 2019 AASLD poster award for work titled "PSC and Artificial Intelligence".
- His Mayo publication list is mostly PSC. Recent examples: a 2026 study using AI on MRI scans to spot early bile duct cancer in people with PSC (Hepatology, January 2026), and a 2026 study on colon pre-cancer after liver transplant in people with both PSC and inflammatory bowel disease, the group that includes ulcerative colitis (Clinical Gastroenterology and Hepatology, January 2026). Both match D.K.'s two main concerns.
- He is the Mayo lead for WIND-PSC, a large observational study of adults with PSC run by PSC Partners. The registry lists Mayo as recruiting, last updated October 13, 2026 (trial record NCT06297993).
- Mayo's own PSC page says its researchers "were among the first to describe PSC" and lists its Hepatobiliary Clinic and Liver Transplant Program among departments that treat it (Mayo PSC doctors and departments page, dated Oct. 15, 2025). That page does not list Dr. Eaton by name (his page lists only one condition, hepatic encephalopathy). It does list other Rochester doctors, including Konstantinos Lazaridis, MD, and Sumera Ilyas, MBBS, if his schedule is full.
- Distance: Rochester is about 11 hours by car from Columbus, or a flight with a connection.
- Still working there: his Mayo page lists a 2021–present committee membership; his publication list includes papers from 2026; the WIND-PSC record updated in October 2026 names him as Mayo's lead.
- Accepting new patients: not stated on his page (see the first-call box in Section 3).
2. Craig S. Lammert, MD — Gastroenterology and Hepatology, IU Health
- Where they practice now: IU Health Gastroenterology & Hepatology, Downtown Indianapolis, Indiana. Checked on IU Health's own page on November 2, 2026: Craig S. Lammert, MD | IU Health
- Why selected:
- His IU Health page says his "clinical interests include autoimmune liver disease, autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis." He trained in liver disease at Mayo Clinic.
- He is listed as an investigator on IU School of Medicine's PSC studies page, with Eric Orman, MD, and Raj Vuppalanchi, MB,BS (two more names at the same office).
- He is IU's lead for the WIND-PSC study, listed as recruiting at IU (NCT06297993).
- A drug trial you can reach by car: a Phase 3 trial of elafibranor in adults with PSC (sponsor: Ipsen) lists Indiana University School of Medicine as recruiting. All the Ohio, Michigan and Minnesota sites, including Cleveland Clinic, Michigan and Mayo, are listed as "not yet recruiting"; the University of Iowa is the other Midwest site listed as recruiting (record updated October 23, 2026; ages 18 to 75; liver still working well, called "compensated") (trial record NCT07387549). Whether D.K. qualifies is a question for the study team.
- IU Health says it did 215 liver transplants in 2024, "the fifth highest volume in the U.S." (the hospital's own figure; IU Health liver transplant page).
- Indianapolis is about 2 h 45 min from Columbus by car.
- To ask him: his IU faculty page says that at IU he "started to focus on autoimmune hepatitis" (a different liver disease) (IU faculty page). Ask how many adults with PSC he follows.
- Still working there: his IU Health page (© 2026) says "Accepting New Patients"; the WIND-PSC record updated October 13, 2026 names him as IU's lead. The page's reviews section did not load for us, so we cannot give a review date.
- Accepting new patients: yes, stated on the page.
3. Nataliya Razumilava, MD — Gastroenterology and Transplant Hepatology, Michigan Medicine
- Where they practice now: University of Michigan Health, Multidisciplinary Liver Clinic at the Rogel Cancer Center, Ann Arbor, Michigan. Checked on Michigan's own page on November 2, 2026: Nataliya Razumilava MD | University of Michigan Health
- Why she is third: her page names "Liver cancer, cholangiocarcinoma, biliary disorders, and advanced liver diseases" and calls her a specialist in "biliary disorders (cholangiopathies)". PSC is one of those bile duct disorders, but her page does not say "PSC" by name, so we placed her after the two doctors whose pages do.
- Why she is still listed:
- Bile duct cancer is the family's stated worry, and it is her focus. She is Associate Director of Michigan's Liver Tumor Program.
- She co-wrote "Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Effective and justified?" (Clinical Liver Disease, 2016), with Gregory Gores of Mayo (University of Michigan library record).
- Michigan's liver transplant page says it is "one of only 20 programs in the country that offers liver transplant for hilar cholangiocarcinoma" (a bile duct cancer type common in PSC), and that it offers living donor transplant. Both are the hospital's own statements.
- Ann Arbor is about 3 hours from Columbus by car.
- Still working there: her Michigan page shows patient comments dated December 10, 2025 and August 3, 2025.
- Accepting new patients: not stated on her page (see the first-call box).
Numbers in this section that do not mean much. The transplant counts and survival rates above are each hospital's own figures, from different years, not audited by us, and not comparable between hospitals. A high transplant count also does not tell you how many PSC patients a doctor follows before transplant. Star ratings on these pages (4.9 vs 5.0) are too close and too general to separate doctors.
Closer to home (Columbus): Ohio State, a local liver team without a named PSC doctor
Sarah Johnson, APRN-CNP — Nurse Practitioner, liver diseases, Ohio State University Wexner Medical Center. Checked on Ohio State's page on November 2, 2026.
- Her page says she regularly cares for patients with conditions including "primary sclerosing cholangitis (PSC)". It says she is accepting new patients, and shows patient reviews dated July 28 and July 21, 2026.
- She is a nurse practitioner, not a physician. On Ohio State's pages we did not find a physician whose page names PSC. Khalid Mumtaz, MBBS, a transplant hepatologist there, is accepting new patients (reviews dated August 24, 2026), but his page does not mention PSC.
- Ohio State has a liver transplant program in Columbus. Its transplant page says it is "one of two locations in Ohio able to perform adult living liver donor transplants" (its own statement).
- How it may help: as the Columbus team for routine MRI scans, labs and follow-up, with one of the three specialists above directing the plan. Ask the Ohio State liver clinic which of its physicians follows the most PSC patients.
Leads we checked and did not list
- Cleveland Clinic (about 2 h 15 min away): it has a liver transplant program (Dr. O'Shea's page places him in its Transplantation Center) and is a site for the elafibranor trial ("not yet recruiting"). We checked three hepatologists from the PSC Partners list. Each has a current page, but none of the pages, as we could read them, names PSC: Robert O'Shea, MD (reviews dated September 28, 2026; his page lists end-stage liver disease, transplant, viral hepatitis and drug-induced liver disease); Christina Lindenmeyer, MD (reviews dated October 20, 2026; her page centers on critically ill liver patients); William Carey, MD (reviews dated September 11, 2026; his page calls him the department's "senior hepatologist"). A web search snippet suggests PSC appears in Dr. O'Shea's condition list, but that section would not open for us. Cleveland Clinic is a reasonable fallback: ask its liver clinic for the hepatologist who follows the most PSC patients.
- Bo Shen, MD: the PSC Partners list still places him at Cleveland Clinic. His Columbia University page says he "comes to Columbia/NewYork-Presbyterian from the Cleveland Clinic", where he now directs the IBD Center in New York. That entry is out of date.
- Lanla Conteh, MD (Ohio State): on the PSC Partners list; an Ohio State bile duct and liver tumor leader in older listings. Her Ohio State profile link sent us to the general "Find a Doctor" search page on November 2, 2026, so we could not confirm she still practices there. Not listed; ask the clinic.
- Alexander Miethke, MD (Cincinnati Children's): a PSC researcher, named on PSC study records updated in August 2026, but a children's doctor. D.K. is an adult.
- UC Health, Cincinnati (about 1 h 45 min away): has a PSC page that says it has "experts in liver disease, IBD, and advanced endoscopy" and gives the Liver Transplant team's line, 513-584-9999 (UC Health PSC page). We could not tie a named Cincinnati hepatologist to PSC on UC Health's own pages.
- Other Mayo names (Lazaridis, Ilyas, LaRusso): on Mayo's PSC page (dated Oct. 15, 2025), but we did not open their individual pages, so they are named only as backups at Mayo.
- Online doctor-ranking directories: not used; their scores do not show PSC experience.
3. Next steps
How to reach each specialist (from each institution's own page, checked November 2, 2026):
- Mayo Clinic (Dr. Eaton):
- Phone: 507-910-0182 (on his page), or the Rochester Central Appointment Office 507-538-3270, 7 a.m.–6 p.m. Central, Monday–Friday (Mayo appointments page). Online request form on his page.
- WIND-PSC study at Mayo: Paige Powrie, Powrie.Paige@mayo.edu (as listed in the trial registry, which the study sponsor maintains).
- IU Health (Dr. Lammert):
- Phone: 317-944-0980; "Book Online" on his page.
- IU Health liver transplant program: 800-382-4602 or transplantinfo@iuhealth.org.
- WIND-PSC at IU: Rebecca Gerstorff, rebgerst@iu.edu. Elafibranor trial: the registry lists only the sponsor's contact, clinical.trials@ipsen.com; ask Dr. Lammert's office who runs it at IU.
- Michigan Medicine (Dr. Razumilava):
- Phone: 734-647-8902 (on her page). Her page says Michigan "participates with most health insurance plans."
- Transplant Center: 1-800-333-9013; the transplant page has a referral form "for self-referrals and referring providers".
- Ohio State (Columbus): liver clinic 614-293-6255 (on Sarah Johnson's and Dr. Mumtaz's pages); transplant appointments 614-293-4100.
- PSC Partners: (303) 771-5227 or contactus@pscpartners.org (on its provider map page).
Your first call — three questions
No page we read gives the wait for a new patient. Mayo's and Michigan's pages do not say whether these doctors take new patients, and no page says whether video visits to Ohio are possible. Ask on the first call:
1. Is Dr. [name] seeing new adult patients with PSC, and what is the current wait for a first visit?
2. Do you need a referral from my doctor, or can I refer myself?
3. Can you review my MRCP images, labs and colonoscopy reports before I travel? After the first visit, can follow-ups be video visits to Ohio, with scans done in Columbus?
Your 3 steps this week:
- Ask your GI doctor's office for copies of these records:
- every MRI/MRCP report, plus the image files on a disc or secure link (the specialist will want to look at the images, not only the report)
- liver blood tests over time (alkaline phosphatase, bilirubin, ALT/AST, albumin, platelets) and any CA 19-9 results
- all colonoscopy and biopsy reports for the ulcerative colitis
- any ERCP, liver biopsy, ultrasound or liver stiffness (FibroScan or MR elastography) reports
- a current medication list and the visit notes
- Call or email two of the specialists above. One way to choose: Mayo for the deepest PSC focus, and IU if driving distance or the elafibranor trial matters, or Michigan if bile duct cancer is the main worry. Use the three questions in the box.
- Call your insurer (questions below), then call your HR benefits office if the answers are unclear.
Insurance questions for an employer PPO (ask, and write down the answer, name and date):
- Are Mayo Clinic (Rochester, MN), IU Health (Indianapolis, IN) and University of Michigan Health (Ann Arbor, MI) in network? If not, what do I pay for an out-of-network specialist visit and MRI?
- Do MRI/MRCP scans, ERCP or a liver transplant evaluation need prior authorization? Who submits it: the specialist or my Columbus doctor?
- If a transplant is ever needed: does my plan require a specific transplant network or "center of excellence"? Does it pay any travel or lodging benefit?
- If I join a clinical trial, what does my plan cover for routine care during the trial?
- Is my employer plan self-funded? (Your HR office can tell you; it changes which rules apply to appeals.)
- Federal protections to know:
- The health care law says job-based plans cannot set lifetime or yearly dollar limits on essential health benefits (HealthCare.gov page).
- The No Surprises Act "protects people from unexpected medical bills" in certain out-of-network situations (CMS page).
- If a claim is denied, you have the right to an internal appeal and to an external review by an independent third party (HealthCare.gov page).
Other paths if the first plan does not work:
- Local-first: see the Ohio State liver clinic now and ask for a PSC-focused physician there, then book one expert visit at Mayo, IU or Michigan for a long-term plan.
- Trial-first: ask Dr. Lammert's office about the elafibranor trial and the WIND-PSC study. WIND-PSC is also open at Mayo.
- Cleveland Clinic is the closest large transplant and IBD center (see "Leads we checked").
- PSC Partners runs a patient registry ("Join the Registry" link at the top of its home page); ask what joining involves.
4. Stories from families who have been there
- A wife's account on a patient foundation website (American Liver Foundation, April 20, 2020): Jim.
- Jim had PSC for 13 years and also had ulcerative colitis. He kept working as a union electrician, and the family "lived normally" for years.
- After two bile duct infections and three ERCPs, he was found to have bile duct cancer in November 2007. Their Boston hospital did not offer transplant for that cancer, so they were sent to Mayo Clinic in Rochester for chemotherapy, radiation and then a living donor transplant in April 2008.
- Recovery included infections, feeding tubes, septic shock and a blood clot. His wife writes that he "no longer has PSC, cholangiocarcinoma, or cirrhosis."
- Tone: frightening, then grateful. One very good result, not a typical one. Read it
- A patient's own Q&A on the PSC Partners website (page dated April 15, 2026; he writes that his transplant was five months earlier, so the text is from early 2023): Jason Sparks, age 42.
- He has ulcerative colitis (since 1999), autoimmune hepatitis and PSC (found in 2011–2012). For years his only signs were tiredness and slightly yellow eyes.
- From June 2021 to November 2022 he spent 24 nights in the hospital over six stays: two bile duct infections, a complication after an ERCP, gallbladder removal "to preempt any potential gallbladder cancer", internal bleeding, and a cancer scare that "ultimately wound up being benign."
- He had a liver transplant at UCSF in California on October 29, 2022. He is also PSC Partners' top fundraiser, so he is not a neutral voice.
- Tone: honest about how hard the years were, upbeat now. Read it
- A patient foundation press release (PSC Partners, August 27, 2025): Michelle Murphy, Madison, Wisconsin.
- She learned she had PSC at 19 and kept it private for 30 years. In 2024 she learned she needed a transplant.
- At a PSC Partners conference she wore a shirt with a QR code asking for a living liver donor. Brooke Babcock, the mother of a teenager with PSC, was already "three-quarters of the way" through becoming a living donor. She saw the shirt and offered to be tested for Michelle.
- After nearly a year of tests, Brooke gave part of her liver to Michelle at Mayo Clinic in Rochester on August 26, 2025. The release was written the next day, so it says nothing about recovery.
- Tone: hopeful; written by the foundation. Read it
- A Columbus story, labelled as hospital marketing: Ohio State's liver transplant page links a short video, "Two-time liver transplant: Justin." Its summary says a routine physical showed ulcerative colitis and PSC, "an illness he would need a liver transplant for to survive." The title says he needed two transplants. We read only the summary, not the video. Ohio State video
- Hard outcomes: we did not find a first-person account of a death from PSC. The AASLD page notes that bile duct cancer found late has "a very poor prognosis." These stories come from people well enough to share them. Ask your specialist about results for patients like you.
5. Ready-to-send messages
Email to the specialist's office (copy, fill the brackets, send):
Subject: New patient request — primary sclerosing cholangitis (PSC) with ulcerative colitis — records review
Hello, I am writing about myself. My GI doctor recently told me I have primary sclerosing cholangitis (PSC), and I have had ulcerative colitis for [years]. I am 57 and live in Columbus, Ohio.
Dr. [Eaton / Lammert / Razumilava]'s work with PSC is why I am contacting your program. Could you tell me:
(1) whether Dr. [name] is seeing new adult patients with PSC, (2) the current wait for a first visit,
(3) whether a referral is needed, and (4) how to send my MRCP images, liver tests and colonoscopy reports for review before a visit?
I would also like to know whether follow-up visits could be by video, with scans and labs done in Columbus, and whether I might fit any PSC study you are running.
My insurance is [plan name, PPO, member ID]. Thank you, [name, phone]
Phone script (what to say in the first 30 seconds): "Hi, I'm calling to request a new patient appointment with Dr. [name] for primary sclerosing cholangitis, or PSC, with ulcerative colitis. Is Dr. [name] currently seeing new adult patients with PSC? What's the wait? Do you need a referral, and how do I send my MRCP images and reports before the visit?" Write down: the person's name, the date, the answer, the next step.
6. One-page summary to bring to the appointment
Name: ____________ Date of birth: ____________ Phone: ____________ Condition: primary sclerosing cholangitis (PSC). Date I was told: ____________ By whom: ____________ Ulcerative colitis: since (year) ______ Last colonoscopy date and result: ____________ Current colitis medicine: ____________ Key test results (fill in from your copies):
- Alkaline phosphatase: ______ Bilirubin: ______ ALT/AST: ______ Albumin: ______ Platelets: ______
- CA 19-9 (if done): ______
- Last MRI/MRCP date and main finding (any "dominant stricture"?): ____________
- Liver stiffness (FibroScan or MR elastography) if done: ______
- Gallbladder ultrasound (any polyps?): ______
Symptoms now: itching / yellow eyes or skin / fevers with chills / tiredness / right-side belly pain / weight loss (circle) · Since when: ______ Past bile duct infections, ERCPs or hospital stays: ____________ Current medicines and doses: ____________ Allergies: ____________ My local doctors (name, phone): ____________ The 3 questions that matter most to me today:
- ____________
- ____________
- ____________
What I want from this visit: (for example: a written cancer-screening schedule, a colonoscopy plan, and who does what in Columbus) ____________
7. Questions to ask the specialist
- How many adults with PSC do you personally follow each year? How many also have ulcerative colitis? And your team?
- What results do you see for patients like me, in the next few years and longer term?
- How long is the wait for a first visit, and can you review my MRCP images and reports before I travel?
- Is my PSC the "large-duct" or "small-duct" type? Does that change my risks or which studies I could join?
- What is my bile duct cancer screening plan: MRI/MRCP how often, CA 19-9 or not, and what happens if a result looks abnormal? Who reads my scans: a radiologist who reads many PSC scans?
- Colonoscopy: the AASLD page lists every 1–2 years with pre-cancer checks for people with PSC and colitis. Who should do mine, and with which technique?
- Do I need a gallbladder ultrasound? What would you do if a polyp is found?
- How much scarring does my liver have now? Do I need checks for cirrhosis or swollen veins (varices)?
- When would you send me for a transplant evaluation? Does your center do living donor transplants, and transplants for bile duct cancer?
- When would you do an ERCP, and who on your team does them?
- Should I take, keep or stop ursodiol (ursodeoxycholic acid)? Am I a fit for the elafibranor trial, the WIND-PSC study, or the PSC Partners registry?
- Can my Columbus doctors do the routine scans, labs and colonoscopies while you direct the plan? Can follow-ups be video visits?
- What warning signs should make me call you or go to the ER (fever with chills, new yellow skin or eyes, dark urine, belly pain, vomiting blood or black stools)?
8. Your support after this report
- 14 days of email questions about this report: reply to the delivery email.
- Day-30 check-in: we email you. If you could not get an appointment with any listed specialist, we research new options at no charge.
- Not helpful? Tell us within 7 days and we redo the research once at no charge; if it still doesn't help, we refund you in full.
This report is general information to help you find and talk to specialists. It is not medical advice, does not identify or confirm any condition, and does not recommend a treatment. Treatment decisions belong to you and your doctors. No doctor or hospital pays to be included in this report. The patient in this sample report is fictional; the specialists, pages and stories are real and were checked on November 2, 2026.
Want this research for your own situation?
Tell us the condition and your state. We confirm we can cover it before you pay anything.
Check my case — free